Cargando…

Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families

BACKGROUND: To determine whether non-viral nasopharyngeal carcinoma (NPC) risk factors might be associated with (and mediated through) Epstein–Barr virus (EBV) serological responses linked to NPC risk, we evaluated predictors of risk of anti-EBNA1 IgA seropositivity and other markers among unaffecte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, C M, Yu, K J, Hsu, W L, Major, J M, Chen, J Y, Lou, P J, Liu, M Y, Diehl, S R, Goldstein, A M, Chen, C J, Hildesheim, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251852/ https://www.ncbi.nlm.nih.gov/pubmed/22095229 http://dx.doi.org/10.1038/bjc.2011.502

Ejemplares similares

Efficacy of Chemiluminescence Immunoassays on VCA-IgA and EBNA1-IgA Antibodies of Epstein-Barr Virus in Diagnosing Nasopharyngeal Carcinoma
por: Yu, Xia, et al.
Publicado: (2020)

EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
por: Huo, Shaofen, et al.
Publicado: (2020)

A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma
por: Song, Changxin, et al.
Publicado: (2013)

Correlation Analysis of Nasopharyngeal Carcinoma TNM Staging with Serum EA IgA and VCA IgA in EBV and VEGF-C and -D
por: Sun, Ruimei, et al.
Publicado: (2015)

The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency
por: Styles, Christine T., et al.
Publicado: (2018)

Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma
por: Ye, Qian, et al.
Publicado: (2021)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1976)

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
por: Paschos, Kostas, et al.
Publicado: (2012)

Novel Patterns of the Epstein-Barr Nuclear Antigen (EBNA-1) V-Val Subtype in EBV-associated Nasopharyngeal Carcinoma from Vietnam
por: Thuan, LD, et al.
Publicado: (2019)

EBV-IgA antibody responses in endemic and nonendemic populations with nasopharyngeal carcinoma: tumour marker prognostication study and a cross-sectional study
por: Budiningsih, Insani, et al.
Publicado: (2023)

Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis
por: Bhattacharjee, Shaoni, et al.
Publicado: (2016)

Targeted disruption of EBNA1 in EBV-infected cells attenuated cell growth
por: Noh, Ka-Won, et al.
Publicado: (2016)

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

PARP1 Inhibition Halts EBV+ Lymphoma Progression by Disrupting the EBNA2/MYC Axis
por: Napoletani, Giorgia, et al.
Publicado: (2023)

Development of a Duplex Serological Multiplex Assay for the Simultaneous Detection of Epstein-Barr Virus IgA and IgG Antibodies in Nasopharyngeal Carcinoma Patients
por: Schieber, Jennifer, et al.
Publicado: (2023)

PLK1‐dependent phosphorylation restrains EBNA2 activity and lymphomagenesis in EBV‐infected mice
por: Zhang, Xiang, et al.
Publicado: (2021)

EBV persistence without its EBNA3A and 3C oncogenes in vivo
por: Murer, Anita, et al.
Publicado: (2018)

Immunological abnormalities in patient with IgA nephropathy.
por: Ihm, C. G., et al.
Publicado: (1986)

Elevated EBNA-1 IgG in MS is associated with genetic MS risk variants
por: Kreft, Karim L., et al.
Publicado: (2017)

Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children
por: Ai, Junhong, et al.
Publicado: (2012)

EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)
Publicado: (1990)

Dissecting the contribution of EBNA3C domains important for EBV-induced B-cell growth and proliferation
por: Jha, Hem Chandra, et al.
Publicado: (2015)

Serum EA-IgA and d-dimer, but not VCA-IgA, are associated with prognosis in patients with nasopharyngeal carcinoma: a meta-analysis
por: Liang, Tianhao, et al.
Publicado: (2021)

IgA in the horse: cloning of equine polymeric Ig receptor and J chain and characterization of recombinant forms of equine IgA
por: Lewis, M J, et al.
Publicado: (2010)

IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
por: Ho, H. C., et al.
Publicado: (1977)

Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden
por: Ärlestig, Lisbeth, et al.
Publicado: (2011)

Whole-Exome Sequencing of Nasopharyngeal Carcinoma Families Reveals Novel Variants Potentially Involved in Nasopharyngeal Carcinoma
por: Yu, Guoqin, et al.
Publicado: (2019)

Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
por: Hertle, Marie L., et al.
Publicado: (2009)

Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival
por: Bhattacharjee, Shaoni, et al.
Publicado: (2018)

Similarities between the Epstein-Barr Virus (EBV) Nuclear Protein EBNA1 and the Pioneer Transcription Factor FoxA: Is EBNA1 a “Bookmarking” Oncoprotein that Alters the Host Cell Epigenotype?
por: Niller, Hans Helmut, et al.
Publicado: (2012)

IgA—about the unexpected
por: Macpherson, Andrew J., et al.
Publicado: (2018)

Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

Rabbit IgA Hinges That Resist IgA1 Protease Action Provide Options for Improved IgA-Based Therapeutic Agents
por: de Sousa-Pereira, Patrícia, et al.
Publicado: (2022)

Messenger RNA Sequence Rather than Protein Sequence Determines the Level of Self-synthesis and Antigen Presentation of the EBV-encoded Antigen, EBNA1
por: Tellam, Judy T., et al.
Publicado: (2012)

Increased Urinary IgA in Paediatric IgA Vasculitis Nephritis
por: Marro, Julien, et al.
Publicado: (2022)

EBNA2 driven enhancer switching at the CIITA-DEXI locus suppresses HLA class II gene expression during EBV infection of B-lymphocytes
por: Su, Chenhe, et al.
Publicado: (2021)

Rapid detection of quantum dot immune chromatography nasopharyngeal carcinoma EBNA1 antibody
por: He, Jian, et al.
Publicado: (2018)

EBV genome carrying B lymphocytes that express the nuclear protein EBNA-2 but not LMP-1: Type IIb latency
por: Klein, Eva, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ic64njupi0cb7l3epdsobktu36